Levosimendan Intermediate CAS 36725-28-7 Purity > 99.5% (HPLC) Hoobkas
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-3(2H)-Pyridazinone (CAS: 36725-28-7) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Tshuaj npe | 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-3(2H)-Pyridazinone |
Synonyms | 6-(p-Aminophenyl)-5-methyl-4,5-dihydro-3(2H)-pyridazinone;1,4-Dihydro-4-Methyl-3-(4-Aminophenyl)pyridazine-6(5H)-ib ;Levosimendan Impurity 5 |
CAS Nr | 36725-28-7 |
CAT Number | RF-PI 1976 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C11H13N3O |
Molecular Luj | 203.25 Nws |
Melting Point | 194.0 txog 198.0 ℃ |
Qhov ntom | 1.30 ± 0.10g / cm3 |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Off-White to Pale Brownish Color Powder |
Kev txheeb xyuas (HPLC) | HPLC RT ntawm lub ncov loj sib raug rau cov qauv kev ua haujlwm hauv tsev |
Poob rau ziab | <0.50% |
Residue ntawm Ignition | <0.20% |
Yam khoom muaj feem | (HPLC) |
Ib leeg Impurity | <0.20% |
Tag nrho cov impurities | <0.50% |
Purity / Analysis Method | > 99.5% (HPLC) |
Hnyav Hlau | <20 ppm |
Proton NMR Spectrum | Raws li tus qauv |
Test Standard | Enterprise Standard |
Kev siv | Intermediate of Levosimendan (CAS: 141505-33-1) |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo
6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-3(2H)-Pyridazinone (CAS: 36725-28-7) yog ib qho nruab nrab ntawm Levosimendan (CAS: 141505-33-1).Levosimendan tau qhia nyob rau hauv Sweden raws li ib tug iv infusion rau kev kho mob ntawm mob plawv tsis ua hauj lwm los yog refractory tsos mob ntawm lub plawv tsis ua hauj lwm nyob rau hauv cov neeg mob uas cov pa kev kho mob (xws li, diuretic los yog ACE inhibitor) tsis txaus.Nws kuj ua rau lub ventricular thiab arterial adenostne triphosphate-tswj cov poov tshuaj raws uas ua rau vasodilatation hauv vascular du nqaij thiab tiv thaiv myocardium tiv thaiv infarction.Nws qhov qis phosphodiesterase III inhibiting kev ua haujlwm yog tej zaum tsis muaj lub luag haujlwm rau nws qhov zoo inotropic, lusitropic thiab dilating teebmeem.Tsis zoo li lwm cov tshuaj cardiotonic, levosimendan muaj peev xwm tsim cov teebmeem inotropic zoo yam tsis muaj kev ncua ntev ntawm myocardial so lossis ua rau muaj qhov tshwm sim ntawm malignant arrythmias.Nws tau raug kuaj pom tias muaj kev pheej hmoo tsawg dua ntawm kev tuag hauv cov neeg mob plawv tsis ua haujlwm thaum piv rau cov placebo thiab dobutamine.Txij li thaum nws muaj peev xwm loj dua, levosimendan tam sim no nyob rau hauv kev soj ntsuam ntxiv raws li kev kho mob ntev rau lub plawv tsis ua hauj lwm.